We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Advanced Melanoma

Journal Scan / Research · November 09, 2020

Immune Checkpoint Inhibition for Advanced Skin Cancer in Patients With Concomitant Hematological Malignancy

Journal for immunotherapy of cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal for immunotherapy of cancer
Immune Checkpoint Inhibition Therapy for Advanced Skin Cancer in Patients With Concomitant Hematological Malignancy: A Retrospective Multicenter DeCOG Study of 84 Patients
J Immunother Cancer 2020 Oct 01;8(2)e000897, U Leiter, C Loquai, L Reinhardt, D Rafei-Shamsabadi, R Gutzmer, K Kaehler, L Heinzerling, JC Hassel, V Glutsch, J Sirokay, N Schlecht, A Rübben, T Gambichler, K Schatton, C Pfoehler, C Franklin, P Terheyden, S Haferkamp, P Mohr, L Bischof, E Livingstone, L Zimmer, M Weichenthal, D Schadendorf, A Meiwes, U Keim, C Garbe, JC Becker, S Ugurel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading